China SXT Pharmaceuticals (SXTC) Payables (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Payables of $852823.0 for Q1 2026, down 54.16% year-over-year from $1.9 million in Q1 2025, and down 43.41% quarter-over-quarter from $1.5 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Payables (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Payables history runs 9 years deep, the most recent figure standing at $852823.0 for Q1 2026.
- In Q1 2026, Payables fell 54.16% year-over-year to $852823.0; the TTM figure through Mar 2026 stood at $852823.0 (down 54.16% YoY), while the FY2026 annual figure was $852823.0, down 54.16% from the prior year.
- Payables for Q1 2026 stood at $852823.0, down from $1.5 million in the prior quarter.
- The five-year high for Payables was $3.5 million in Q1 2022, with the low at $852823.0 in Q1 2026.
- The 5-year median for Payables is $1.6 million (2022), against an average of $1.8 million.
- The sharpest annual moves came in 2023 and 2024: Payables tumbled 56.22% in 2023, then jumped 78.93% in 2024.
- China SXT Pharmaceuticals' Payables stood at $1.6 million in 2022, then decreased by 15.34% to $1.3 million in 2023, then jumped by 78.93% to $2.4 million in 2024, then sank by 36.28% to $1.5 million in 2025, then plunged by 43.41% to $852823.0 in 2026.
- Business Quant data shows SXTC's Payables at $852823.0 in Q1 2026, $1.5 million in Q3 2025, and $1.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 986.00 Mn |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - | 852,823.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 852,823.00 |
| Sep 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Sep 30, 2021 | 1.52 Mn |
| Mar 31, 2021 | 3.08 Mn |
| Sep 30, 2020 | 1.40 Mn |
| Mar 31, 2020 | 1.99 Mn |
| Sep 30, 2019 | 2.02 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Sep 30, 2018 | 2.19 Mn |
| Mar 31, 2018 | 2.79 Mn |